HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$2.34
Day range
$2.26 - $2.41
Year range
$0.95 - $2.82
Market cap
23.77M USD
Avg Volume
305.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 15.14M | 3.71% |
Operating expense | 9.61M | -15.76% |
Net income | -19.82M | -329.24% |
Net profit margin | -130.94 | -313.84% |
Earnings per share | -0.08 | — |
EBITDA | 1.93M | 61.57% |
Effective tax rate | -2.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.95M | 54.71% |
Total assets | 124.18M | 5.15% |
Total liabilities | 105.21M | 16.41% |
Total equity | 18.97M | — |
Shares outstanding | 9.91M | — |
Price to book | 1.11 | — |
Return on assets | 1.29% | — |
Return on capital | 3.22% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.82M | -329.24% |
Cash from operations | 2.80M | 455.71% |
Cash from investing | -3.02M | -8,773.53% |
Cash from financing | 12.99M | 1,116.57% |
Net change in cash | 12.78M | 5,094.72% |
Free cash flow | -2.24M | -248.83% |
About
Founded
2002
Headquarters
Website
Employees
83
